Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Nov 2023 – 20 Aug 2026, limited by DSP Gold ETF Fund of Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Gold ETF Fund of Fund | Gold |
|---|---|---|
| 20 Nov 2023 | ₹100.00 | ₹100.00 |
| 12 Feb 2024 | ₹102.08 | ₹102.19 |
| 05 May 2024 | ₹115.88 | ₹117.07 |
| 28 Jul 2024 | ₹111.87 | ₹116.12 |
| 20 Oct 2024 | ₹125.03 | ₹126.17 |
| 11 Jan 2025 | ₹125.49 | ₹127.62 |
| 05 Apr 2025 | ₹143.86 | ₹145.16 |
| 28 Jun 2025 | ₹153.03 | ₹154.49 |
| 19 Sep 2025 | ₹174.58 | ₹176.71 |
| 12 Dec 2025 | ₹209.58 | ₹212.18 |
| 06 Mar 2026 | ₹250.22 | ₹253.23 |
| 28 May 2026 | ₹246.83 | ₹249.79 |
| 20 Aug 2026 | ₹246.62 | ₹249.48 |
| Metric | DSP · Direct NAV ₹24.57 High risk ★★★★☆ 1Y | Category median FoF Domestic · 151 funds |
|---|---|---|
| +56.88% | +8.79% | |
| — | +14.76% | |
| — | +11.89% | |
| — | +12.34% | |
| +38.87% | +11.30% | |
| +41.98% | — | |
| — | +13.06% | |
| — | +10.96% | |
| — | +10.76% | |
| Risk | ||
| 22.41% | 15.95% | |
| 2.25 | 0.81 | |
| 3.23 | 1.14 | |
| -25.22% | -19.45% | |
| Gold | — | |
| -0.42% | +1.81% | |
| 1.00 | 0.94 | |
| 98.3% | 98.0% | |
| 96.6% | 93.1% | |
| 0.63% | 0.17% | |
| ₹503.12Cr | ₹228.08Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 11% | |
| Anil Ghelani | — | |
| 20 Nov 2023 | — | |
| — | — | |
| — | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.